The Public Health Company
PHC Global specializes in biological threat intelligence and risk management to protect humankind and capital. Their modular hardware and scalable software empower national security agencies and commercial enterprises with biointelligence to detect, prevent, prepare for, respond to, and recover from biological threats. They serve national security agencies and commercial enterprises with tailored intelligence about any pathogen, including natural, accidental, and biologically engineered threats. Their technology utilizes AI and deep epidemiological expertise to assess biothreats in real time, ensuring readiness against known and unknown biological threats.
The Public Health Company
PHC Global specializes in biological threat intelligence and risk management to protect humankind and capital. Their modular hardware and scalable software empower national security agencies and commercial enterprises with biointelligence to detect, prevent, prepare for, respond to, and recover from biological threats. They serve national security agencies and commercial enterprises with tailored intelligence about any pathogen, including natural, accidental, and biologically engineered threats. Their technology utilizes AI and deep epidemiological expertise to assess biothreats in real time, ensuring readiness against known and unknown biological threats.
TL;DR
Founded: 2020
Headquarters: Palo Alto, California
Product: SaaS-enabled global biosecurity / bio-risk intelligence platform
Primary customers: Governments (national security agencies) and commercial enterprises
Known funding stage: Series A
Company Overview
Problem Domain
Biological threat intelligence, biosecurity, and enterprise disease-risk management.
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
43000000
Investor Signal
“Includes institutional investors such as ImpactAssets, Venrock, Verily, Cleveland Capital Management, Sweat Equity Ventures, and The General Partnership”